Where Will AI Have the Biggest Impact? Healthcare.

Recently, we received an email about a healthcare panel entitled “Using AI with Modern Fax Capabilities to Reduce Administrative Burden.”

We immediately thought, “wait, what?”

But yes, we had read it correctly: There was a panel on integrating AI with fax machines in healthcare!

Are we stuck in the 1980s? Shouldn’t healthcare just get with the times and stop using fax machines?

We had to laugh.

But under the surface, this email tells us a lot.

It reveals why AI will have a bigger impact in healthcare than in any other industry and why AI talent should be incredibly excited by that opportunity.

Hear us out.

It’s no secret that traditional enterprise software has struggled to penetrate healthcare. Emails about “modern fax capabilities” demonstrate this pretty clearly. Healthcare is 20% of the American economy, but only one of the largest 100 public software companies is a healthcare company.

The successful healthcare software companies are incredible businesses, but they are few and far between. Healthcare as an industry has been slow to adopt technology, reluctant to burden overwhelmed IT teams, and train burned-out staff on new systems.

But that is about to change.

Just as emerging markets went straight from using cash to mobile payments (“leapfrogging” credit cards altogether), healthcare is going to move straight from fax machines to AI (“leapfrogging” traditional vertical software).

With AI, healthtech companies no longer need to fight the uphill battle of training people on software. Instead, they can sell AI that acts like a person and takes more and more of the work off healthcare professionals’ plates, enabling them to work on more interesting problems and practice at the top of their licenses.

The pitch is simple: “Don’t want more software? Cool, we can give you AI ‘people’ who are cheap, fast, cheerful and empathic.”

We believe that any new technology has to be 10 times better to successfully displace the last one—marginal improvements aren’t worth the effort. Enterprise software struggled to clear that 10x bar in healthcare; AI clears it easily.

This revolution will start with the non-clinical use cases. AI will take on the work of call centers, scheduling, prior authorization, medical coding, revenue cycle management, and fighting medical bills.

But the clinical revolution is not far behind. AI can already pass the medical licensing exam to become a doctor and read an x-ray as well as a radiologist. Soon, AI’s accuracy in diagnosing medical issues and recommending treatment plans will surpass humans. Every doctor will have an AI copilot assisting them. Regulatory pathways already exist to bring clinical AI to market, and we’re encouraged by early signals of partnership by lawmakers and regulators.

And this is incredibly exciting for every person on the planet.

The biggest challenges in healthcare are (1) access—there aren’t enough enough good doctors to provide timely care to all who need it (and clinicians are leaving the field in droves due to burn out), and (2) cost—the cost of healthcare has skyrocketed, largely because of increasing labor costs.

AI will solve both of these issues.

When it comes to access, people won’t have to wait months to get quality care. As AI improves, every single person will have a world-class AI doctor in their pocket, spanning all medical specialities. Diagnoses will come months earlier, allowing expedited, AI-guided interventions by doctors who focus their time in more impactful ways.

When it comes to cost, AI will radically decrease spend by shifting care from all-human services to AI-augmented services. Note this is not true in industries that are already software driven—AI is more expensive than enterprise SaaS. But it’s way less expensive than human services, and healthcare is a $4 trillion industry that is mainly human services. AI will help us achieve a future where every person can afford world-class medical care, and medical debt is no longer the number one cause of bankruptcy.

Over the past few decades, almost every major industry has been majorly upleveled by technology. Healthcare is the biggest prize that remains. We know the AI hype cycle has hit healthcare before, but we’re excited by today’s overlap of data availability, public foundation models, and widespread interest. And as we’ve said before, most impactful companies are built at the frontier, and healthcare is the next frontier.

So to any skeptics doubting that AI will have the biggest impact in healthcare, here’s what we have to say:

Find us another industry where AI can solve the industry’s two biggest challenges and save countless lives along the way. We’ll wait.

In the meantime, we’ll be investing in the future so we can tell our grandchildren stories about the panels on fax machines back in our day.

***

The views expressed here are those of the individual AH Capital Management, L.L.C. (“a16z”) personnel quoted and are not the views of a16z or its affiliates. Certain information contained in here has been obtained from third-party sources, including from portfolio companies of funds managed by a16z. While taken from sources believed to be reliable, a16z has not independently verified such information and makes no representations about the enduring accuracy of the information or its appropriateness for a given situation. In addition, this content may include third-party advertisements; a16z has not reviewed such advertisements and does not endorse any advertising content contained therein.

This content is provided for informational purposes only, and should not be relied upon as legal, business, investment, or tax advice. You should consult your own advisers as to those matters. References to any securities or digital assets are for illustrative purposes only, and do not constitute an investment recommendation or offer to provide investment advisory services. Furthermore, this content is not directed at nor intended for use by any investors or prospective investors, and may not under any circumstances be relied upon when making a decision to invest in any fund managed by a16z. (An offering to invest in an a16z fund will be made only by the private placement memorandum, subscription agreement, and other relevant documentation of any such fund and should be read in their entirety.) Any investments or portfolio companies mentioned, referred to, or described are not representative of all investments in vehicles managed by a16z, and there can be no assurance that the investments will be profitable or that other investments made in the future will have similar characteristics or results. A list of investments made by funds managed by Andreessen Horowitz (excluding investments for which the issuer has not provided permission for a16z to disclose publicly as well as unannounced investments in publicly traded digital assets) is available at https://a16z.com/investments/.

Charts and graphs provided within are for informational purposes solely and should not be relied upon when making any investment decision. Past performance is not indicative of future results. The content speaks only as of the date indicated. Any projections, estimates, forecasts, targets, prospects, and/or opinions expressed in these materials are subject to change without notice and may differ or be contrary to opinions expressed by others. Please see https://a16z.com/disclosures for additional important information.